SEC ownership of CYBIN INC.

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001833141.

Comparable stake leader

Venrock Healthcare Capital Partners III, L.P.

Disclosed value leader

Venrock Healthcare Capital Partners III, L.P.

Comparable rows

50/50

Latest evidence

30 Jun 2026

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 3 signals
Comparable ownership rows
50 of 50
Meaning: Rows with safely comparable ownership %
Latest 13D/G holder
Venrock Healthcare Capital Partners III, L.P.
Source: Latest parsed Schedule 13D/G stake
Latest parsed ownership date
30 Jun 2026
Freshness: Most recent filing date in this holder set
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0001833141
Issuer location
Toronto, Ontario, Canada

Ownership snapshot

Top shareholders of CYBIN INC. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Venrock Healthcare Capita...
Disclosed value leader
Venrock Healthcare Capita...
Comparable rows
50/50
Latest evidence
30 Jun 2026
13D/G 13F Lead comparable stake: 9.9% 13D/G row: Venrock Healthcare Capital Partners III, L.P. Showing 1-8 of 50 holder rows.

Quick read

Venrock Healthcare Capital Partners III, L.P. leads the comparable SEC ownership view at 9.9%.

50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Venrock Healthcare Capital Partners III, L.P.'s linked filing trail.
Comparable ownership Top 5
Venrock Healthcare Capital Partne... 9.9%
MILLENNIUM MANAGEMENT LLC 5.7%
Adage Capital Management, L.P. 5.3%
ORBIMED ADVISORS LLC 4.9%
Sirenia Capital Management LP 4.8%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-8 of 50 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Venrock Healthcare Capital Partners III, L.P.
13D/G
9.9%
$30,106,217
5,111,412 shares
$0 31 Oct 2025
MILLENNIUM MANAGEMENT LLC
13F 13D/G
Company
5.7%
from 13D/G
$17,398,551
2,632,156 shares
30 Jun 2026
Adage Capital Management, L.P.
13D/G
5.3%
$21,807,728
3,289,250 shares
$0 30 Jun 2026
ORBIMED ADVISORS LLC
13F 13D/G
Company · ORBIMED CAPITAL LLC
4.9%
from 13D/G
$21,623,954
3,271,400 shares
30 Jun 2026
Sirenia Capital Management LP
13D/G
4.8%
$20,085,585
3,029,500 shares
$0 30 Jun 2026
Deep Track Capital, LP
13D/G
4.7%
$18,486,334
2,391,505 shares
-$5,262,159 31 Dec 2025
Point72 Asset Management, L.P.
13F 13D/G
Company
1.4%
from 13D/G
$703,681
106,457 shares
30 Jun 2026
Venrock Adviser, LLC
13F
Company
13F
6.1%
$25,459,433
3,851,654 shares
30 Jun 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 21 Aug 2025.

Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 0 Shares: 0
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 0 0 $0 $0 $0
3-6 0 0 $0 $0 $0
6-9 0 0 $0 $0 $0
9-12 0 0 $0 $0 $0

Recent insider transactions for CYBIN INC.

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
No insider transactions were found in the last 12 months for this issuer.
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .